SAKAR HEALTHCARE LTD Q3 RESULTS
Drug formulations pep up sector, but contract research spoils Q3 party
However, pharma companies mainly into formulations have managed to show strong growth, except for those who had operations in Germany and suffered losses due to regulatory changes for drug procurement.
US profits rise 23% in Q3, but pace may slow
Third-Quarter earnings of US companies rose an average of 23%, led by investment banks including Goldman Sachs Group and insurer Allstate.
'Safe bets' pharma & FMCG crumble in Q3; net dips on poor demand
Pharmaceutical firms and makers of consumer goods such as soaps and shampoos are considered as reliable defensive bets in times of economic distress.
Stocks buzz: Top four stocks to track in volatile markets
Markets have been topsy-turvy so far in the month of April, with the benchmark index losing nearly 3 per cent as FIIs booked profits.
Brokers' Call: Nestle, Fortis, Maruti
For Nestle India, CY12 earmarked a year of portfolio rationalisation and channel optimisation, resulting in a modest revenue growth of 10.8% compared to revenue CAGR of 21.6% over CY06-CY11.
Brokers’ Call: Fortis Health, Cummins India, BEL, Asian Paints and NMDC
'Buy' and 'Sell' call by various brokerages for stocks like Fortis Health, Cummins India, BEL, Asian Paints and NMDC.
Wipro results in line with market expectations: analysts
Wipro Ltd on Wednesday posted an “in line with the market expectations” performance clocking a net profit growth of 18.76 per cent at Rs 978 crore for the Q2 September 2008.
High pressure on pharma margins; buy JB Chemicals: Sharekhan
Lupin and Glenmark as clear winners with a likely upside from Para IV/niche opportunities, strong domestic franchise, low vulnerability to $ exposure and cost containment measures protecting the operating leverage.
Delayed projects slow Wipro’s Q1 growth
For the second quarter, Wipro has forecast flat 2 per cent growth.
Equities end on a high note for fourth day, IndusInd shines
Optimism in global markets on the back of a possible trade truce between US and China did the trick.
Stocks in the news: YES Bank, TCS, Ashok Leyland, Raymond, Pfizer and IL&FS Transport
Here are a few stocks which by buzz the most in today's trade.
The week that was: Jet's hard landing, gold rush for PCJ & Polycab listing
Shares of jewellery maker PCJ climbed 29.70 per cent during the week to Rs 145.20.
Stocks drop into red ahead of macro data
The indices defied positive cues from global markets and strength in the rupee to settle lower.
Market Movers: What changed for D-Street while you were sleeping
Check out what might matter on Dalal Street all through the day.
Buy Tata Consultancy Services, target Rs 2,400: Sharekhan
Buy Tata Consultancy Services at a price target of Rs 2,400.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service